GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (MEX:ZTS) » Definitions » Cyclically Adjusted PB Ratio

Zoetis (MEX:ZTS) Cyclically Adjusted PB Ratio : 20.56 (As of Jun. 02, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Zoetis Cyclically Adjusted PB Ratio?

As of today (2025-06-02), Zoetis's current share price is MXN3207.55. Zoetis's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was MXN156.01. Zoetis's Cyclically Adjusted PB Ratio for today is 20.56.

The historical rank and industry rank for Zoetis's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEX:ZTS' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 19.13   Med: 29.88   Max: 47
Current: 21.7

During the past years, Zoetis's highest Cyclically Adjusted PB Ratio was 47.00. The lowest was 19.13. And the median was 29.88.

MEX:ZTS's Cyclically Adjusted PB Ratio is ranked worse than
98.12% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs MEX:ZTS: 21.70

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zoetis's adjusted book value per share data for the three months ended in Mar. 2025 was MXN213.508. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN156.01 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zoetis Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Zoetis's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Cyclically Adjusted PB Ratio Chart

Zoetis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.18 46.55 26.56 30.21 21.73

Zoetis Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.68 24.46 26.72 21.73 21.18

Competitive Comparison of Zoetis's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zoetis's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zoetis's Cyclically Adjusted PB Ratio falls into.


;
;

Zoetis Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zoetis's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3207.55/156.01
=20.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Zoetis's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=213.508/134.9266*134.9266
=213.508

Current CPI (Mar. 2025) = 134.9266.

Zoetis Quarterly Data

Book Value per Share CPI Adj_Book
201506 36.952 100.684 49.519
201509 41.674 100.392 56.010
201512 36.921 99.792 49.920
201603 40.398 100.470 54.252
201606 50.658 101.688 67.216
201609 62.008 101.861 82.137
201612 62.204 101.863 82.395
201703 61.661 102.862 80.882
201706 63.310 103.349 82.654
201709 73.993 104.136 95.871
201712 71.507 104.011 92.761
201803 73.461 105.290 94.139
201806 80.262 106.317 101.860
201809 82.368 106.507 104.347
201812 89.462 105.998 113.878
201903 93.826 107.251 118.038
201906 96.925 108.070 121.013
201909 110.896 108.329 138.123
201912 107.402 108.420 133.660
202003 135.938 108.902 168.424
202006 144.907 108.767 179.758
202009 167.434 109.815 205.722
202012 157.732 109.897 193.657
202103 175.975 111.754 212.463
202106 182.600 114.631 214.929
202109 203.242 115.734 236.946
202112 197.207 117.630 226.206
202203 196.824 121.301 218.933
202206 196.624 125.017 212.210
202209 201.089 125.227 216.665
202212 185.163 125.222 199.513
202303 175.146 127.348 185.569
202306 172.090 128.729 180.376
202309 192.488 129.860 199.999
202312 185.049 129.419 192.923
202403 183.706 131.776 188.098
202406 200.474 132.554 204.063
202409 228.234 133.029 231.490
202412 221.823 133.157 224.771
202503 213.508 134.927 213.508

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zoetis  (MEX:ZTS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zoetis Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Zoetis's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis Business Description

Industry
Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.